other_material
confidence high
sentiment neutral
materiality 0.65
Celularity raises $2M initial tranche in $6.67M private placement of Series A Preferred and warrants
Celularity Inc
- Series A Preferred shares sold at 90% of stated value; $2M initial tranche closed Oct 24, 2025.
- Up to three tranches totaling $6.67M stated value; warrants exercisable at $3.00/share for 25% of purchase price.
- Conversion price lower of 110% of prior close or 95% of 7-day VWAP, floor $1.60; 5% dividend (18% on trigger event).
- Proceeds used for working capital; investor capped at 4.99% beneficial ownership unless waived.
- Shares issued exempt under Section 4(a)(2) and Regulation D; resale registration required within 30 days.
item 1.01item 3.02item 5.03item 9.01